EMPOWERCTA
Device
ACIST MEDICAL SYSTEMS, INC.
Total Payments
$22,257
Transactions
3
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2019 | $22,257 | 3 | 2 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $14,727 | 1 | 66.2% |
| Travel and Lodging | $4,380 | 1 | 19.7% |
| Consulting Fee | $3,150 | 1 | 14.2% |
Payments by Type
Research
$14,727
1 transactions
General
$7,530
2 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| ACCELERATION CLINICAL STUDY - ADENOSINE CONTRAST CORRELATIONS IN EVALUATING REVASCULARIZATION | ACIST MEDICAL SYSTEMS, INC. | $14,727 | 0 |
Top Doctors Receiving Payments for EMPOWERCTA
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Durham, NC | $14,727 | 1 |
| Massoud Leesar | Interventional Cardiology | Birmingham, AL | $4,380 | 1 |
| , M.D | Internal Medicine | Cleveland, OH | $3,150 | 1 |
Ad
Manufacturing Companies
- ACIST MEDICAL SYSTEMS, INC. $22,257
Product Information
- Type Device
- Total Payments $22,257
- Total Doctors 2
- Transactions 3
About EMPOWERCTA
EMPOWERCTA is a device associated with $22,257 in payments to 2 healthcare providers, recorded across 3 transactions in the CMS Open Payments database. The primary manufacturer is ACIST MEDICAL SYSTEMS, INC..
Payment data is available from 2019 to 2019. In 2019, $22,257 was paid across 3 transactions to 2 doctors.
The most common payment nature for EMPOWERCTA is "Unspecified" ($14,727, 66.2% of total).
EMPOWERCTA is associated with 1 research study, including "ACCELERATION CLINICAL STUDY - ADENOSINE CONTRAST CORRELATIONS IN EVALUATING REVASCULARIZATION" ($14,727).